These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

688 related items for PubMed ID: 16393292

  • 21. The positive predictive value of guaiac faecal occult blood test in relation to the number of positive squares in two consecutive rounds of colorectal cancer screening.
    Manfredi S, Philip J, Campillo B, Piette C, Durand G, Riou F, Bretagne JF.
    Eur J Cancer Prev; 2011 Jul; 20(4):277-82. PubMed ID: 21633201
    [Abstract] [Full Text] [Related]

  • 22. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
    Rozen P, Levi Z, Hazazi R, Waked A, Vilkin A, Maoz E, Birkenfeld S, Leshno M, Niv Y.
    Aliment Pharmacol Ther; 2009 Apr 15; 29(8):906-17. PubMed ID: 19183147
    [Abstract] [Full Text] [Related]

  • 23. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report.
    Young GP, St John DJ, Winawer SJ, Rozen P, WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy).
    Am J Gastroenterol; 2002 Oct 15; 97(10):2499-507. PubMed ID: 12385430
    [Abstract] [Full Text] [Related]

  • 24. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
    Brenner H, Tao S.
    Eur J Cancer; 2013 Sep 15; 49(14):3049-54. PubMed ID: 23706981
    [Abstract] [Full Text] [Related]

  • 25. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F, Sonnenberg A.
    Ital J Gastroenterol Hepatol; 1999 Mar 15; 31(2):119-26. PubMed ID: 10363196
    [Abstract] [Full Text] [Related]

  • 26. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
    Hol L, de Jonge V, van Leerdam ME, van Ballegooijen M, Looman CW, van Vuuren AJ, Reijerink JC, Habbema JD, Essink-Bot ML, Kuipers EJ.
    Eur J Cancer; 2010 Jul 15; 46(11):2059-66. PubMed ID: 20621736
    [Abstract] [Full Text] [Related]

  • 27. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme.
    Faivre J, Dancourt V, Manfredi S, Denis B, Durand G, Gendre I, Bidan JM, Jard C, Levillain R, Jung S, Viguier J, Dorval E.
    Dig Liver Dis; 2012 Aug 15; 44(8):700-4. PubMed ID: 22542582
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
    Hoff G, Grotmol T, Thiis-Evensen E, Bretthauer M, Gondal G, Vatn MH.
    Gut; 2004 Sep 15; 53(9):1329-33. PubMed ID: 15306594
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Fletcher RH, Ransohoff DF, Imperiale TF.
    Cancer; 2007 May 01; 109(9):1925-6; author reply 1926. PubMed ID: 17370313
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
    Graser A, Stieber P, Nagel D, Schäfer C, Horst D, Becker CR, Nikolaou K, Lottes A, Geisbüsch S, Kramer H, Wagner AC, Diepolder H, Schirra J, Roth HJ, Seidel D, Göke B, Reiser MF, Kolligs FT.
    Gut; 2009 Feb 01; 58(2):241-8. PubMed ID: 18852257
    [Abstract] [Full Text] [Related]

  • 37. Screening for colorectal cancer with immunochemical faecal occult blood tests.
    Faivre J, Dancourt V, Lejeune C.
    Dig Liver Dis; 2012 Dec 01; 44(12):967-73. PubMed ID: 22898146
    [Abstract] [Full Text] [Related]

  • 38. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
    Lohsiriwat V, Thavichaigarn P, Awapittaya B.
    J Med Assoc Thai; 2007 Nov 01; 90(11):2291-5. PubMed ID: 18181309
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.